South & Central America Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarrays), Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)
The South & Central America sepsis diagnostics market is expected to grow from US$ 38.66 million in 2021 to US$ 69.59 million by 2028. It is estimated to record a CAGR of 8.8% from 2021 to 2028.
High Incidence of Sepsis due to Increasing Nosocomial Infections Fuels South & Central America Sepsis Diagnostics Market Growth
Infection is the root cause of sepsis. Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and chronic illnesses like diabetes. Among several types of infections, nosocomial infections are the primary cause of morbidity and mortality among hospitalized patients. Most deaths can be prevented through early diagnosis and appropriate clinical management. These deaths are often a consequence of diarrheal diseases or lower respiratory infections. Thus, the high incidence rate of sepsis is expected to boost the demand for sepsis diagnostic products, thereby supporting the South & Central America sepsis diagnostics market growth during the forecast period.
South & Central America Sepsis Diagnostics Market Overview
The South & Central America sepsis diagnostics market is segmented into Argentina, Brazil, and the Rest of South & Central America. The market growth in the region is attributed to the rising aging population and increasing burden of sepsis cases in the region.
South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Sepsis Diagnostics Market Segmentation
The South & Central America sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, end user, and country.
Based on product, the South & Central America sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.
Based on technology, the South & Central America sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.
Based on method, the South & Central America sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.
Based on test type, the South & Central America sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.
Based on pathogen, the South & Central America sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.
Based on end user, the South & Central America sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.
Based on country, the South & Central America sepsis diagnostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market share in 2021.
Abbott; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; and THERMO FISHER SCIENTIFIC INC. are among the leading companies operating in the South & Central America sepsis diagnostics market.
High Incidence of Sepsis due to Increasing Nosocomial Infections Fuels South & Central America Sepsis Diagnostics Market Growth
Infection is the root cause of sepsis. Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and chronic illnesses like diabetes. Among several types of infections, nosocomial infections are the primary cause of morbidity and mortality among hospitalized patients. Most deaths can be prevented through early diagnosis and appropriate clinical management. These deaths are often a consequence of diarrheal diseases or lower respiratory infections. Thus, the high incidence rate of sepsis is expected to boost the demand for sepsis diagnostic products, thereby supporting the South & Central America sepsis diagnostics market growth during the forecast period.
South & Central America Sepsis Diagnostics Market Overview
The South & Central America sepsis diagnostics market is segmented into Argentina, Brazil, and the Rest of South & Central America. The market growth in the region is attributed to the rising aging population and increasing burden of sepsis cases in the region.
South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Sepsis Diagnostics Market Segmentation
The South & Central America sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, end user, and country.
Based on product, the South & Central America sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.
Based on technology, the South & Central America sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.
Based on method, the South & Central America sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.
Based on test type, the South & Central America sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.
Based on pathogen, the South & Central America sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.
Based on end user, the South & Central America sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.
Based on country, the South & Central America sepsis diagnostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market share in 2021.
Abbott; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; and THERMO FISHER SCIENTIFIC INC. are among the leading companies operating in the South & Central America sepsis diagnostics market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Sepsis Diagnostics Market – By Product
1.3.2 South & Central America Sepsis Diagnostics Market – By Technology
1.3.3 South & Central America Sepsis Diagnostics Market – By Method
1.3.4 South & Central America Sepsis Diagnostics Market – By Test Type
1.3.5 South & Central America Sepsis Diagnostics Market – By Pathogen
1.3.6 South & Central America Sepsis Diagnostics Market – By End User
1.3.7 South & Central America Sepsis Diagnostics Market – By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Experts Opinion
5. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
5.4.1 Rising Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis
6. SEPSIS DIAGNOSTICS MARKET– SOUTH & CENTRAL AMERICA ANALYSIS
6.1 South & Central America Sepsis Diagnostics Market Revenue Forecast and Analysis
7. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028– BY PRODUCT
7.1 Overview
7.2 South & Central America Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
7.4.1 Overview
7.4.2 Reagents and Assays: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
7.5.1 Overview
7.5.2 Blood Culture Media: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – TECHNOLOGY
8.1 Overview
8.2 South & Central America Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
8.3 Molecular Diagnostics
8.3.1 Overview
8.3.2 Molecular Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Polymerase Chain Reaction
8.3.2.1.1 Overview
8.3.2.1.2 Polymerase Chain Reaction: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
8.3.2.2.1 Overview
8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Syndromic Panel-Based Testing
8.3.2.3.1 Overview
8.3.2.3.2 Syndromic Panel-Based Testing: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Microarrays
8.3.2.4.1 Overview
8.3.2.4.2 Microarrays: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
8.4.1 Overview
8.4.2 Flow Cytometry: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4.3 Real-Time Cell Analysis
8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture
8.4.3.1.1 Characteristics of TaqMan Assays
8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) – Case Study
8.4.3.2.1 Abstract
8.4.3.2.2 Conclusion:
8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions
8.4.3.4 Sepsis diagnosis by real-time PCR
8.4.3.5 New next-generation sequencing technique and technological advancements/innovations
8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements
8.4.4 Real-Time Cell Analysis: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
8.5.1 Overview
8.5.2 Microfluidics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
8.6.1 Overview
8.6.2 Immunoassay: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
8.7.1 Overview
8.7.2 Biomarkers: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.3 Metabolomics
8.7.3.1 Metabolite Profile in Sepsis
8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis
8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling
8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis
8.7.3.4.1 Genomics
8.7.3.4.2 Proteomics
8.7.3.5 Sepsis Biomarkers and Diagnostic Tools
8.7.3.6 Role Metabolomics and Proteomics in Sepsis
8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis
8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis
8.7.3.9 Metabolics in Mitochondrial Function
8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine
8.7.4 Metabolomics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
8.8.1 Overview
8.8.2 Microbiology: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – METHOD
9.1 Overview
9.2 South & Central America Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
9.3 Automated Diagnostics
9.3.1 Overview
9.3.2 Automated Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
9.4.1 Overview
9.4.2 Conventional Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – TEST TYPE
10.1 Overview
10.2 South & Central America Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
10.3 Point-of-Care Tests
10.3.1 Overview
10.3.2 Point-of-Care Tests: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
10.4.1 Overview
10.4.2 Laboratory Tests: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – PATHOGEN
11.1 Overview
11.2 South & Central America Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
11.3 Bacterial Sepsis
11.3.1 Overview
11.3.2 Bacterial Sepsis: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
11.4.1 Overview
11.4.2 Fungal Sepsis: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – END USER
12.1 Overview
12.2 South & Central America Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
12.3 Hospitals
12.3.1 Overview
12.3.2 Hospitals: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
12.4.1 Overview
12.4.2 Pathology and Reference Laboratories: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
12.5.1 Overview
12.5.2 Others: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
13. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – COUNTRY ANALYSIS
13.1 Overview
13.1.2 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
13.1.2.1 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.1.1 Overview
13.1.2.1.2 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.1.3 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
13.1.2.1.4 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.1.4.1 Biomarkers: Metabolomics 2019-2028
13.1.2.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.2.1.4.3 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.1.5 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.1.6 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.1.7 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.1.8 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.1.2.2 Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.2.1 Overview
13.1.2.2.2 Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.2.3 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
13.1.2.2.4 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.2.4.1 Biomarkers: Metabolomics 2019-2028
13.1.2.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.2.2.4.3 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.2.5 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.2.6 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.2.7 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.2.8 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.1.2.3 Rest of South & Central America: Sepsis Diagnostics Market– Revenue and Forecast to 2028 (US$ Mn)
13.1.2.3.1 Overview
13.1.2.3.2 Rest of South & Central America: Sepsis Diagnostics Market– Revenue and Forecast to 2028 (US$ Mn)
13.1.2.3.3 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
13.1.2.3.4 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.3.4.1 Biomarkers: Metabolomics 2019-2028
13.1.2.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.2.3.4.3 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.3.5 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.3.6 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.3.7 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.3.8 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
14. SEPSIS DIAGNOSTICS MARKET–INDUSTRY LANDSCAPE
14.1 Overview
14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. COMPANY PROFILES
15.1 Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. HOFFMANN-LA ROCHE LTD.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 BD
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Danaher (Beckman Coulter)
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 THERMO FISHER SCIENTIFIC INC.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 bioMerieux SA
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
16. APPENDIX
16.1 About the Insight Partners
16.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Sepsis Diagnostics Market – By Product
1.3.2 South & Central America Sepsis Diagnostics Market – By Technology
1.3.3 South & Central America Sepsis Diagnostics Market – By Method
1.3.4 South & Central America Sepsis Diagnostics Market – By Test Type
1.3.5 South & Central America Sepsis Diagnostics Market – By Pathogen
1.3.6 South & Central America Sepsis Diagnostics Market – By End User
1.3.7 South & Central America Sepsis Diagnostics Market – By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Experts Opinion
5. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
5.4.1 Rising Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis
6. SEPSIS DIAGNOSTICS MARKET– SOUTH & CENTRAL AMERICA ANALYSIS
6.1 South & Central America Sepsis Diagnostics Market Revenue Forecast and Analysis
7. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028– BY PRODUCT
7.1 Overview
7.2 South & Central America Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
7.4.1 Overview
7.4.2 Reagents and Assays: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
7.5.1 Overview
7.5.2 Blood Culture Media: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – TECHNOLOGY
8.1 Overview
8.2 South & Central America Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
8.3 Molecular Diagnostics
8.3.1 Overview
8.3.2 Molecular Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Polymerase Chain Reaction
8.3.2.1.1 Overview
8.3.2.1.2 Polymerase Chain Reaction: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
8.3.2.2.1 Overview
8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Syndromic Panel-Based Testing
8.3.2.3.1 Overview
8.3.2.3.2 Syndromic Panel-Based Testing: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Microarrays
8.3.2.4.1 Overview
8.3.2.4.2 Microarrays: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
8.4.1 Overview
8.4.2 Flow Cytometry: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4.3 Real-Time Cell Analysis
8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture
8.4.3.1.1 Characteristics of TaqMan Assays
8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) – Case Study
8.4.3.2.1 Abstract
8.4.3.2.2 Conclusion:
8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions
8.4.3.4 Sepsis diagnosis by real-time PCR
8.4.3.5 New next-generation sequencing technique and technological advancements/innovations
8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements
8.4.4 Real-Time Cell Analysis: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
8.5.1 Overview
8.5.2 Microfluidics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
8.6.1 Overview
8.6.2 Immunoassay: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
8.7.1 Overview
8.7.2 Biomarkers: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.3 Metabolomics
8.7.3.1 Metabolite Profile in Sepsis
8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis
8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling
8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis
8.7.3.4.1 Genomics
8.7.3.4.2 Proteomics
8.7.3.5 Sepsis Biomarkers and Diagnostic Tools
8.7.3.6 Role Metabolomics and Proteomics in Sepsis
8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis
8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis
8.7.3.9 Metabolics in Mitochondrial Function
8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine
8.7.4 Metabolomics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
8.8.1 Overview
8.8.2 Microbiology: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – METHOD
9.1 Overview
9.2 South & Central America Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
9.3 Automated Diagnostics
9.3.1 Overview
9.3.2 Automated Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
9.4.1 Overview
9.4.2 Conventional Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – TEST TYPE
10.1 Overview
10.2 South & Central America Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
10.3 Point-of-Care Tests
10.3.1 Overview
10.3.2 Point-of-Care Tests: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
10.4.1 Overview
10.4.2 Laboratory Tests: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – PATHOGEN
11.1 Overview
11.2 South & Central America Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
11.3 Bacterial Sepsis
11.3.1 Overview
11.3.2 Bacterial Sepsis: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
11.4.1 Overview
11.4.2 Fungal Sepsis: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – END USER
12.1 Overview
12.2 South & Central America Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
12.3 Hospitals
12.3.1 Overview
12.3.2 Hospitals: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
12.4.1 Overview
12.4.2 Pathology and Reference Laboratories: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
12.5.1 Overview
12.5.2 Others: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
13. SOUTH & CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – COUNTRY ANALYSIS
13.1 Overview
13.1.2 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
13.1.2.1 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.1.1 Overview
13.1.2.1.2 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.1.3 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
13.1.2.1.4 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.1.4.1 Biomarkers: Metabolomics 2019-2028
13.1.2.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.2.1.4.3 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.1.5 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.1.6 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.1.7 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.1.8 Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.1.2.2 Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.2.1 Overview
13.1.2.2.2 Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.2.3 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
13.1.2.2.4 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.2.4.1 Biomarkers: Metabolomics 2019-2028
13.1.2.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.2.2.4.3 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.2.5 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.2.6 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.2.7 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.2.8 Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.1.2.3 Rest of South & Central America: Sepsis Diagnostics Market– Revenue and Forecast to 2028 (US$ Mn)
13.1.2.3.1 Overview
13.1.2.3.2 Rest of South & Central America: Sepsis Diagnostics Market– Revenue and Forecast to 2028 (US$ Mn)
13.1.2.3.3 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
13.1.2.3.4 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.3.4.1 Biomarkers: Metabolomics 2019-2028
13.1.2.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.2.3.4.3 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.3.5 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.3.6 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.3.7 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.3.8 Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
14. SEPSIS DIAGNOSTICS MARKET–INDUSTRY LANDSCAPE
14.1 Overview
14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. COMPANY PROFILES
15.1 Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. HOFFMANN-LA ROCHE LTD.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 BD
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Danaher (Beckman Coulter)
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 THERMO FISHER SCIENTIFIC INC.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 bioMerieux SA
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
16. APPENDIX
16.1 About the Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. New next-generation sequencing techniques by Company
Table 2. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 3. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 4. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 5. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 6. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 7. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 8. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 9. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 10. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 11. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 12. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 13. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 14. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 15. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 16. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 17. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 18. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 19. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 20. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 21. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 22. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 23. Recent Organic Growth Strategies in Sepsis Diagnostics Market
Table 24. Inorganic Developments in the Sepsis Diagnostics Market
Table 25. Glossary of Terms
Table 1. New next-generation sequencing techniques by Company
Table 2. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 3. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 4. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 5. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 6. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 7. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 8. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 9. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 10. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 11. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 12. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 13. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 14. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 15. Argentina: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 16. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 17. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 18. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 19. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 20. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 21. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 22. Rest of South & Central America: South & Central America Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 23. Recent Organic Growth Strategies in Sepsis Diagnostics Market
Table 24. Inorganic Developments in the Sepsis Diagnostics Market
Table 25. Glossary of Terms
LIST OF FIGURES
Figure 1. South & Central America Sepsis Diagnostics Market Segmentation
Figure 2. South & Central America Sepsis Diagnostics Market, By Country
Figure 3. South & Central America Sepsis Diagnostics Market Overview
Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in South & Central America Sepsis Diagnostics Market
Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. South & Central America Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. South & Central America Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
Figure 11. Instruments: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Reagents and Assays: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Blood Culture Media: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Software: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. South & Central America Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
Figure 16. Molecular Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. Polymerase Chain Reaction: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18. Peptide Nucleic Acid-Fluorescent in Situ Hybridization: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. Syndromic Panel-Based Testing: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. Microarrays: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. Flow Cytometry: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. Real-Time Cell Analysis: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. Microfluidics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Immunoassay: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Biomarkers: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Metabolomics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. Microbiology: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. South & Central America Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
Figure 29. Automated Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Conventional Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. South & Central America Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
Figure 32. Point-of-Care Tests: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Laboratory Tests: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. South & Central America Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
Figure 35. Bacterial Sepsis: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Fungal Sepsis: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. Others: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38. South & Central America Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
Figure 39. Hospitals: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. Pathology and Reference Laboratories: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 41. Others: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 42. South and Central America Sepsis Diagnostics Market Revenue Overview, by Key Country, 2021 (US$ Million)
Figure 43. South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
Figure 44. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 45. Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 46. Rest of South & Central America: Sepsis Diagnostics Market– Revenue and Forecast to 2028 (US$ Mn)
Figure 47. Growth Strategies in the Sepsis Diagnostics Market (%)
Figure 1. South & Central America Sepsis Diagnostics Market Segmentation
Figure 2. South & Central America Sepsis Diagnostics Market, By Country
Figure 3. South & Central America Sepsis Diagnostics Market Overview
Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in South & Central America Sepsis Diagnostics Market
Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. South & Central America Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. South & Central America Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
Figure 11. Instruments: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Reagents and Assays: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Blood Culture Media: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Software: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. South & Central America Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
Figure 16. Molecular Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. Polymerase Chain Reaction: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18. Peptide Nucleic Acid-Fluorescent in Situ Hybridization: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. Syndromic Panel-Based Testing: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. Microarrays: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. Flow Cytometry: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. Real-Time Cell Analysis: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. Microfluidics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Immunoassay: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Biomarkers: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Metabolomics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. Microbiology: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. South & Central America Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
Figure 29. Automated Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Conventional Diagnostics: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. South & Central America Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
Figure 32. Point-of-Care Tests: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Laboratory Tests: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. South & Central America Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
Figure 35. Bacterial Sepsis: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Fungal Sepsis: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. Others: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38. South & Central America Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
Figure 39. Hospitals: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. Pathology and Reference Laboratories: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 41. Others: South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 42. South and Central America Sepsis Diagnostics Market Revenue Overview, by Key Country, 2021 (US$ Million)
Figure 43. South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
Figure 44. Brazil: South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 45. Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 46. Rest of South & Central America: Sepsis Diagnostics Market– Revenue and Forecast to 2028 (US$ Mn)
Figure 47. Growth Strategies in the Sepsis Diagnostics Market (%)
